Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2021 Feb 16;187(1):135–144. doi: 10.1007/s10549-021-06100-2

Fig. 2.

Fig. 2

Effect of ZOL treatment on TTR (A), TTBR (B), TTNBR (C), BCS (D) and OS (E) in the overall study population including all ages and breast cancer subtypes